Tag: major

Posted on

Tenet’s Heartbeat Platform Achieves Major Milestone with Over 400,000 Insurance Policies Processed

Tenet’s Heartbeat Platform Achieves Major Milestone with Over 400,000 Insurance Policies Processed

Toronto, Ontario–(Newsfile Corp. – April 21, 2022) – Tenet Fintech Group Inc. (CSE: PKK) (OTC PINK: PKKFF) (“Tenet” or the “Corporation”), an ground breaking AI support company and operator of the Business enterprise Hubs™, nowadays announced that its Heartbeat coverage product or service administration and brokerage platform a short while ago handed a big milestone by processing much more than 400,000 insurance policies worth far more than CAD$175M.

Tenet obtained the system in the slide of 2021 to enhance its Enterprise Hub™ services giving in China and in anticipation of authorities laws that came into outcome on February 1, 2022, aimed at increasing the supervision of the insurance coverage brokerage sector and boosting the industry’s selection and administration of details. Those regulations and the compliance obligations they carry have now pushed 381 Chinese insurance brokerage organizations to use Heartbeat to link with, accessibility and sell coverage merchandise from some of China’s leading insurance policy corporations, like Ping An Insurance policy (Group) Ltd., China Lifetime House & Casualty Insurance plan Company Ltd., The People’s Insurance policy Organization (Group) of China Ltd., and Bank of China Coverage Corporation Ltd. with whom the system is connected. Although present day introduced milestone can mainly be attributed to the new insurance coverage brokerage sector regulations and to Tenet’s arrangement with Ping An Insurance policies for procedures aimed at vehicle business, the Business thinks that future milestones and Heartbeat’s impact on China’s coverage sector will arrive as a final result of the function that the system will in the end perform inside of Tenet’s Organization Hub™.

“Our acquisition of Heartbeat was both equally opportunistic and strategic,” claimed Liang Qiu, CEO of Tenet China. “Every system that we acquire, acquisition that we make or partnership that we sign is finished with the intension of making synergies with other parts of our Business enterprise Hub™ and to greatly enhance the Hub’s featuring. The Heartbeat platform is a prime instance of that. Correct now, Heartbeat is remaining used to help offer far more traditional insurance policies goods. But finally, specified the verticals we serve via the Hub, these kinds of as the oil and fuel sector, the car sector and commodities traders, the amount of money of transactional knowledge at our disposal, our analytics capabilities to fully grasp our clients’ requirements and our obtain to the country’s insurance coverage organizations, we feel we are going to be equipped to get the job done with these insurance providers to style and design customized insurance plan goods to flawlessly healthy our clients’ wants and make new chances for our insurance partners.”

About Tenet Fintech Group Inc.:

Tenet Fintech Group Inc. is the guardian business of a team of modern economical technology (Fintech) and synthetic intelligence (AI) companies. All references to Tenet in this news launch, unless explicitly specified, includes Tenet and all its subsidiaries. Tenet’s subsidiaries offer different analytics and AI-centered products and services to enterprises and economical establishments via numerous Business enterprise Hubs™ to generate a global ecosystem in which analytics and AI are used to produce opportunities and aid B2B transactions among the its customers. For extra info: http://www.tenetfintech.com

For additional data, make sure you get in touch with:

CHF Funds Marketplaces
Cathy Hume, CEO
416-868-1079 ext.: 251
cathy@chfir.com

MZ Group – MZ North The usa
Mark Schwalenberg, CFA
312-261-6430
mark.schwalenberg@mzgroup.us

Comply with Tenet Fintech Group Inc. on social media:

Twitter: @Tenetfintech
Fb: @Tenetfintech
LinkedIn: Tenet Fintech
YouTube: Tenet Fintech

Ahead-Looking Statements / Data:

This information launch could consist of specific forward-looking information, which include statements relating to business and operating methods, designs and prospective buyers for revenue development and listing options, using words and phrases together with “foresee”, “believe”, “could”, “be expecting”, “intend”, “could”, “plan”, “opportunity”, “task”, “seek”, “need to”, “will”, “would” and similar expressions, which are supposed to determine a selection of these forward-wanting statements. Forward-searching facts reflects recent views with regard to recent occasions and is not a assurance of potential overall performance and is matter to threats, uncertainties and assumptions. The Enterprise undertakes no obligation to publicly update or evaluation any forward-wanting information contained in this information release, except as could be expected by relevant regulations, procedures and restrictions. Readers are urged to consider these aspects thoroughly in assessing any ahead-on the lookout information and facts.

To check out the supply version of this push launch, you should check out https://www.newsfilecorp.com/launch/121155

Posted on

Jury finds major pharmacy chains helped fuel opioid epidemic

Jury finds major pharmacy chains helped fuel opioid epidemic

(Reuters) — A federal jury Tuesday found that pharmacy chain operators CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc. helped fuel an opioid epidemic in two Ohio counties, in the first trial the companies have faced over the U.S. drug crisis.

After six days of deliberations, jurors in Cleveland federal court concluded that actions by the pharmacy chains helped create a public nuisance that resulted in an oversupply of addictive pain pills and the diversion of those opioids to the black market.

The verdict, which lawyers for the counties confirmed, has the potential to give state and local governments new leverage in their efforts to negotiate settlements that would resolve the thousands of other cases against the pharmacy operators.

“The judgment today against Walmart, Walgreens and CVS represents the overdue reckoning for their complicity in creating a public nuisance,” the plaintiffs’ lawyers said in a joint statement.

Jurors only assessed liability. It is up to U.S. District Judge Dan Polster to decide how much the companies owe to abate, or address, the public nuisance in Ohio’s Lake and Trumbull counties.

He has tentatively scheduled a trial on that question for May 9. The counties’ lawyers have said the costs are potentially $1 billion for each county.

CVS said in a statement that it strongly disagreed with the verdict and planned to appeal, arguing that the court misapplied public nuisance law, which other courts in similar opioid cases have recently declined to apply to drug manufacturers.

“As plaintiffs’ own experts testified, many factors have contributed to the opioid abuse issue, and solving this problem will require involvement from all stakeholders in our health care system and all members of our community,” CVS said.

Representatives for Walgreens and Walmart did not immediately respond to requests for comment.

The trial was the first that any pharmacies had faced over an epidemic that U.S. health officials say had by 2019 resulted in nearly 500,000 opioid overdose deaths over the course of two decades.

At trial, lawyers for Lake and Trumbull counties argued that the pharmacies failed to ensure opioid prescriptions were valid and allowed excessive quantities of addictive pain pills to flood their communities.

The pharmacy operators, among the largest in the United States, denied the allegations. They said they took steps to guard against the diversion of pills and blamed others, including doctors, regulators and drug traffickers, for the epidemic.  

The verdict in the Ohio trial followed recent setbacks for plaintiffs pursuing some of the other 3,300 opioid cases filed against drug manufacturers, distributors and pharmacies nationally.

Oklahoma’s top court on Nov. 9 overturned a $465 million judgment against drugmaker Johnson & Johnson, and a California judge this month ruled in favor of four drugmakers in a case brought by several large counties.

Other trials are underway in New York involving drugmakers Teva Pharmaceutical Industries Ltd. and AbbVie Inc., and in Washington state with the three largest U.S. drug distributors.